What is the optimal fit-for-purpose design in an oncology first-in-human trial?: 3+3 vs. Bayesian logistic regression model

Detalles Bibliográficos
Autor principal: Yum, Sun Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Clinical Pharmacology and Therapeutics 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136082/
https://www.ncbi.nlm.nih.gov/pubmed/32274376
http://dx.doi.org/10.12793/tcp.2020.28.e1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136082/
https://www.ncbi.nlm.nih.gov/pubmed/32274376
http://dx.doi.org/10.12793/tcp.2020.28.e1

Ejemplares similares